Partex AI

Partex is a data-driven biopharmaceutical company that leverages artificial intelligence to optimize the drug discovery and development process. By utilizing its proprietary AI platform, Ontosight, the company integrates vast amounts of structured and unstructured data to identify novel drug targets and repurpose existing therapeutic assets. Partex operates under a "platform-plus-assets" model, combining its computational expertise with a growing internal pipeline focused on oncology, neurology, and rare diseases. The company aims to improve the probability of clinical success while significantly reducing the time and capital required to bring new treatments to market. Headquartered in Germany, Partex maintains a global footprint with operations in Switzerland, the United States, and India.